Literature DB >> 7204572

Studies on the liver to kidney switch of erythropoietin production.

E D Zanjani, J L Ascensao, P B McGlave, M Banisadre, R C Ash.   

Abstract

Although the liver is the major site of erythropoietin (Ep) production in the fetus, this function is assumed by kidneys in the adult. The mechanisms underlying the liver to kidney switch of Ep formation are not understood. We studied the natural progression of this transition in sheep by measuring Ep production in response to anemia in normal and bilaterally nephrectomized fetal and newborn sheep beginning at about 80 d gestation (normal gestation: 140 d). Removal of both kidneys before induction of anemia did not affect Ep formation up to about 120 d of gestation. A significant reduction (29%, P < 0.02) in Ep synthesis was first noted at about 130 d of gestation (initiation of switch). This level of nephrectomy-induced reduction of Ep formation persisted until about 15 d after birth. Thereafter, bilateral nephrectomy caused further significant decreases (P < 0.05) in Ep production, gradually resulting in near total absence of Ep production at about day 40 postpartum (completion of switch). Chronic administration of testosterone (12 mg/wk) or estradiole benzoate (1.5 mg/d, 5 d/wk) to the fetus/newborn beginning at 85-90 d of gestation enhanced or suppressed erythropoiesis, respectively, but failed to affect the time at which the liver to kidney switch was initiated and/or completed. By contrast, a significant delay (P < 0.001) in the onset, but not completion of the switch occurred in animals that were either thyroidectomized or rendered chronically anemic beginning in the second third of the gestation period. Administration of thyroxin (1.2 mg/d, 5 d/wk) to thyroidectomized fetus/newborns not only prevented the delay in the initiation of the switch, but also accelerated the rate at which the switch was completed. These results demonstrate that in sheep (a) the liver to kidney switch of Ep production is initiated in utero during the last third of the gestation period, but is completed after birth, (b) this transition occurs gradually; the assumption of Ep producing capacity by the kidney is not preceded by an abrupt loss of hepatic Ep formation; and (c) the switch is not affected by changes in sex hormone levels during the prenatal-postnatal growth periods, but is profoundly influenced by alterations in thyroid hormone and oxygen supply-demand levels.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7204572      PMCID: PMC370680          DOI: 10.1172/jci110133

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  16 in total

1.  Prenatal endocrine function and the initiation of parturition.

Authors:  J R Challis; G D Thorburn
Journal:  Br Med Bull       Date:  1975-01       Impact factor: 4.291

2.  Evidence for a physiologic role of erythropoietin in fetal erythropoiesis.

Authors:  E D Zanjani; L I Mann; H Burlington; A S Gordon; L R Wasserman
Journal:  Blood       Date:  1974-08       Impact factor: 22.113

3.  Erythropoietin production in the fetus: role of the kidney and maternal anemia.

Authors:  E D Zanjani; E N Peterson; A S Gordon; L R Wasserman
Journal:  J Lab Clin Med       Date:  1974-02

4.  The liver as a source of extrarenal erythropoietin production.

Authors:  W Fried
Journal:  Blood       Date:  1972-11       Impact factor: 22.113

5.  Determination of fetal, placental and neonatal blood volumes in the sheep.

Authors:  R K Creasy; M Drost; M V Green; J A Morris
Journal:  Circ Res       Date:  1970-10       Impact factor: 17.367

6.  Erythropoietin production in the fetal lamb.

Authors:  E D Zanjani; E O Horger; A S Gordon; L N Cantor; D L Hutchinson
Journal:  J Lab Clin Med       Date:  1969-11

7.  Fetal and neonatal erythropoiesis.

Authors:  G Lucarelli; A Porcellini; C Carnevali; A Carmena; F Stohlman
Journal:  Ann N Y Acad Sci       Date:  1968-03-29       Impact factor: 5.691

8.  The effects of fetal thyroidectomy in the ovine fetus.

Authors:  A Bhakthavathsalan; L I Mann; J Ayromlooi; W Kunzel; M Liu
Journal:  Am J Obstet Gynecol       Date:  1977-02-01       Impact factor: 8.661

Review 9.  Erythropoietin.

Authors:  A S Gordon
Journal:  Vitam Horm       Date:  1973       Impact factor: 3.421

10.  Erythropoietin production in the anephric rat. I. Relationship between nephrectomy, time of hypoxic exposure, and erythropoietin production.

Authors:  J C Schooley; L J Mahlmann
Journal:  Blood       Date:  1972-01       Impact factor: 22.113

View more
  26 in total

Review 1.  Recombinant adenovirus as a methodology for exploration of physiologic functions of growth factor pathways.

Authors:  Kevin Wei; Frank Kuhnert; Calvin J Kuo
Journal:  J Mol Med (Berl)       Date:  2007-09-22       Impact factor: 4.599

2.  Erythrocytosis caused by an erythropoietin-producing breast adenocarcinoma.

Authors:  R F Bohnen; M Banisadre; R N Gulbrandson; E D Zanjani
Journal:  West J Med       Date:  1990-04

3.  Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia.

Authors:  Pinelopi P Kapitsinou; Qingdu Liu; Travis L Unger; Jennifer Rha; Olena Davidoff; Brian Keith; Jonathan A Epstein; Sheri L Moores; Connie L Erickson-Miller; Volker H Haase
Journal:  Blood       Date:  2010-07-13       Impact factor: 22.113

Review 4.  Regulation of erythropoiesis by hypoxia-inducible factors.

Authors:  Volker H Haase
Journal:  Blood Rev       Date:  2013-01-03       Impact factor: 8.250

Review 5.  Hypoxic regulation of erythropoiesis and iron metabolism.

Authors:  Volker H Haase
Journal:  Am J Physiol Renal Physiol       Date:  2010-05-05

6.  Erythropoietin concentrations and erythropoiesis in newborns suffering from renal agenesis and congenital kidney diseases.

Authors:  H Fahnenstich; C Dame
Journal:  Eur J Pediatr       Date:  1996-03       Impact factor: 3.183

7.  Cloning and expression of the human erythropoietin gene.

Authors:  F K Lin; S Suggs; C H Lin; J K Browne; R Smalling; J C Egrie; K K Chen; G M Fox; F Martin; Z Stabinsky
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

Review 8.  Erythropoiesis, EPO, macrophages, and bone.

Authors:  Joshua T Eggold; Erinn B Rankin
Journal:  Bone       Date:  2018-03-15       Impact factor: 4.398

9.  Age-dependent expression of the erythropoietin gene in rat liver and kidneys.

Authors:  K U Eckardt; P J Ratcliffe; C C Tan; C Bauer; A Kurtz
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

Review 10.  Survival and proliferative roles of erythropoietin beyond the erythroid lineage.

Authors:  Constance Tom Noguchi; Li Wang; Heather M Rogers; Ruifeng Teng; Yi Jia
Journal:  Expert Rev Mol Med       Date:  2008-12-01       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.